Myriad Genetics
MYGNAlgoritmens signaler
- ›Pris under både MA50 och MA200 (svag trend)
- ›Hög volatilitet (151% årlig)
- ›-67% från 52v-toppen
- ›Svagt 3m-momentum (-39.8%)
📰 Senaste nyheter & analys
Källor: Placera, Nyhetsbyrån Direkt, Google NewsMyriad Genetics, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:MYGN) 2026-08-01 - Seeking Alpha
1 d sedanMyriad Genetics, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:MYGN) 2026-08-01 Seeking Alpha
Seeking AlphaWhy Myriad Genetics (MYGN) Shares Are Falling Today - finance.yahoo.com
1 d sedanWhy Myriad Genetics (MYGN) Shares Are Falling Today finance.yahoo.com
finance.yahoo.comMyriad Genetics, Inc. Stock 12‑Month Price Target Cut to $5.75, Implies 7% Upside - TradingView
2 d sedanMyriad Genetics, Inc. Stock 12‑Month Price Target Cut to $5.75, Implies 7% Upside TradingView
TradingViewMyriad Genetics Stock Drops Sharply After Hours: What Investors Need to Know - Benzinga
2 d sedanMyriad Genetics Stock Drops Sharply After Hours: What Investors Need to Know Benzinga
BenzingaMyriad Genetics (MYGN) Reports Q2 Loss, Misses Revenue Estimates - finance.yahoo.com
3 d sedanMyriad Genetics (MYGN) Reports Q2 Loss, Misses Revenue Estimates finance.yahoo.com
finance.yahoo.comMyriad Genetics (NASDAQ:MYGN) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, Stock Drops 28.6% - StockStory
3 d sedanMyriad Genetics (NASDAQ:MYGN) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, Stock Drops 28.6% StockStory
StockStoryMYRIAD GENETICS ($MYGN) Releases Q2 2026 Earnings - Quiver Quantitative
3 d sedanMYRIAD GENETICS ($MYGN) Releases Q2 2026 Earnings Quiver Quantitative
Quiver QuantitativeIs MYGN Stock a Buy at 0.4x Sales? What Investors Should Weigh - qz.com
2026-07-25Is MYGN Stock a Buy at 0.4x Sales? What Investors Should Weigh qz.com
qz.comMyriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
2025-09-23Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy PR Newswire SALT LAKE CITY and BOSTON, Sept. 23, 2025 SALT LAKE CITY and BOSTON , Sept
SOPHiA GENETICSPR NewswireSecurities Fraud Investigation Into Myriad Genetics, Inc. (MYGN) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
2025-05-08Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Myriad Genetics, Inc. (“Myriad” or the “Company”) (NASD
Myriad GeneticsBusiness WireMyriad Genetics, Inc. (MYGN) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
2025-05-08Law Offices of Howard G. Smith announces an investigation on behalf of Myriad Genetics, Inc. (“Myriad” or the “Company”) (NASDAQ: MYGN) investors concerning the Company’s possible violations of federa
Myriad GeneticsBusiness WireMYGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Myriad Genetics, Inc. and Encourages Investors to Contact the Firm
2024-11-14Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Myriad Genetics, Inc. (“Myriad” or “the Company”) (NASDAQ: MYGN). Investors who pu
Myriad GeneticsBusiness WireBREAST CANCER AWARENESS MONTH: NEW CANCER RISK SURVEY REVEALS RISK FACTORS ARE WIDELY MISUNDERSTOOD
2023-09-28BREAST CANCER AWARENESS MONTH: NEW CANCER RISK SURVEY REVEALS RISK FACTORS ARE WIDELY MISUNDERSTOOD PR Newswire SALT LAKE CITY, Sept. 28, 2023 SALT LAKE CITY , Sept. 28, 2023 /PRNewswire/ -- A new
Myriad GeneticsPR NewswireIllumina and Myriad Genetics expand partnership to broaden access to HRD testing in the United States
2023-03-02Illumina and Myriad Genetics expand partnership to broaden access to HRD testing in the United States PR Newswire SAN DIEGO, March 2, 2023 Strategic partnership offers a unique combination of diagn
IlluminaPR NewswireNew Study Published in Clinical Cancer Research Journal Highlights Use of EndoPredict Test to Inform Treatment for Premenopausal Breast Cancer Patients
2022-08-31Myriad Genetics’ EndoPredict test accurately identified premenopausal women with ER+, HER2- breast cancer who could safely avoid adjuvant chemotherapy SALT LAKE CITY, Aug. 31, 2022 (GLOBE NEWSWIRE) -
Myriad Genetics IncGlobeNewswireMyriad Genetics Partners with Institut für Hämopathologie Hamburg and Centre Georges-Francois LeClerc to Expand Access to Genetic Testing in Europe
2022-08-16Collaboration brings MyChoice CDx Plus Testing to Hamburg, Germany and Dijon, France Latest expansions represent Myriad’s commitment to growing international lab partner program SALT LAKE CITY, Aug.
Myriad Genetics IncGlobeNewswire
Klicket på "Köp i Nordnet" öppnar din Nordnet-app om installerad — där loggar du in med BankID. Annars öppnas Nordnets webbsajt där du kan logga in med BankID på samma sätt.